Approval · Notice of Compliance 1702 · 2001
MYLERAN: Notice of Compliance 1702
Issued November 21, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1702
- Date
- November 21, 2001
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antileukemic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYLERAN | 00004618 | Marketed |
Medicinal ingredients
- BUSULFAN 2 MG per TAB